Anvilab Overview

  • Founded
  • 2007
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 1

Anvilab General Information

Description

Manufacturer of generic pharmaceutical products. The company owns the rights to sell Antigrippin-Maximum, Gepagard, and Inflyunet, pharmaceutical brands and owns the trademark Laborotoria ANVI. It develops life saving drugs for chemotherapy, antiviral and others.

Contact Information

Website
www.anvilab.ru
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Pharmaceuticals
Acquirer
Primary Office
  • Kashirskoye Sh. 22, Building 4
  • Moscow
  • Russia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Anvilab Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Anvilab‘s full profile, request access.

Request a free trial